Albert Labs International (FRA:VB50) Research & Development: €0.61 Mil (TTM As of Sep. 2023)


What is Albert Labs International Research & Development?

Albert Labs International FRA:VB50 Research & Development is €0.61 Mil as of Sep. 2023.

Research & Development is the aggregate amount of research and development expenses during the year. Albert Labs International's Research & Development for the three months ended in Sep. 2023 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 was €0.61 Mil.

Albert Labs International  (FRA:VB50) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Albert Labs International Research & Development Related Terms

Albert Labs International Research & Development Historical Data

* Premium members only.

The historical data trend for Albert Labs International's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Albert Labs International Research & Development Chart

Albert Labs International Annual Data
Trend Dec21 Dec22
Research & Development
0.32 1.05

Albert Labs International Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.53 0.07 0.00 0.00

Albert Labs International Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.61 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.61 Mil mean?
Albert Labs International (FRA:VB50) has a Research & Development of €0.61 Mil as of Sep. 2023. Research and development expense is the total cost for research and development activities. View historical data on Albert Labs International and its competitors.
Is Albert Labs International's Research & Development too high?
Albert Labs International's current Research & Development is €0.61 Mil.
How does Albert Labs International's Research & Development compare to VRTX and REGN?
Albert Labs International's Research & Development of €0.61 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Albert Labs International and its competitors. Albert Labs International's current Research & Development is €0.61 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Albert Labs International stock overvalued right now?
Albert Labs International (FRA:VB50) has a current Research & Development of €0.61 Mil. The current Research & Development is €0.61 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Albert Labs International (FRA:VB50), the current Research & Development is €0.61 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Albert Labs International Business Description

Address 201-6996 Merritt Avenue, Burnaby, BC, CAN, V5J 4R6
Albert Labs International Corp is a laboratory-based, clinical research, and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of a clinical pathway.